)
The news and media division of Thomson Reuters is one of the world's largest international multimedia news providers
The news and media division of Thomson Reuters is one of the world's largest international multimedia news providers
Net profit had included a favorable $620 million tax benefit from court rulings in India
Apple said it "respectfully disagreed" with the FAS ruling and that it would appeal it
The space race between the world's two richest men went into hyperdrive on Tuesday after Tesla chief Elon Musk took a swipe at Jeff Bezos' attempt to challenge a major NASA contract
UBS shares fell 3.0% in morning trade.
US drugmaker Merck & Co joined Gilead Sciences on Tuesday in lending support to India
Apple allegedly abused its dominant position in the mobile applications market
Less than 15% of people infected with COVID-19 actually need hospital care and even fewer will need oxygen, says WHO spokesman Tarik Jasarevic
On Monday, the White House said 10 mn of the 60 mn doses could be cleared for export 'in coming weeks' and the rest by June
Merck has decided to focus on its drugs for Covid after two vaccines failed to generate desired immune responses
The US conglomerate makes N95 face masks
Spot gold was flat at $1,780.90 per ounce by 0957 GMT.
OPEC is responsible for over a third of global production
Swiss drugmaker Novartis on Tuesday said first-quarter core net income fell 4%
Bank releases $400 million of provisions on improved outlook; lender unlikely to repeat level of writebacks through 2021, says CFO
The MSCI world equity index, which tracks shares in 49 countries, fell 0.1% by 0810 GMT
Brent crude was up 40 cents, or 0.6%, at $66.05 a barrel by 0658 GMT
Some mobile advertising analysts believe fewer than one in three users will opt-in, which could diminish the effectiveness and profitability of ad targeting
CEOs from 40 firms on Monday launched a public-private task force to provide India with urgently needed medical supplies.
Total, which aimed to produce its first cargo from the project in 2024, suspended work on March 27 after the militant attack
The proposal would temporarily waive the intellectual property (IP) rights of pharmaceutical companies to allow developing countries to produce vaccines